# Efficacy and Safety of Azeol Nasal Spray Versus Placebo in the Treatment of Early Symptoms of Common Cold in Adults

> **NCT05159271** · NA · COMPLETED · sponsor: **Larena SAS** · enrollment: 144 (actual)

## Conditions studied

- Nasal Congestion

## Interventions

- **DEVICE:** Azeol spray nasal
- **DEVICE:** Placebo nasal spray

## Key facts

- **NCT ID:** NCT05159271
- **Lead sponsor:** Larena SAS
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-22
- **Primary completion:** 2023-03-24
- **Final completion:** 2023-04-25
- **Target enrollment:** 144 (ACTUAL)
- **Last updated:** 2023-11-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05159271

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05159271, "Efficacy and Safety of Azeol Nasal Spray Versus Placebo in the Treatment of Early Symptoms of Common Cold in Adults". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05159271. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*